Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07337564

A Clinical Study Evaluating the Efficacy and Safety of SHR-1139 Injection in Adult Patients With Ulcerative Pyoderma Gangrenosum

Status
Not Yet Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Shandong First Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study was designed to assess the therapeutic efficacy and safety of SHR-1139 Injection in adult patients with ulcerative pyoderma gangrenosum.

Conditions

Interventions

TypeNameDescription
DRUGSHR-1139 InjectionSHR-1139 Injection

Timeline

Start date
2026-02-01
Primary completion
2027-12-01
Completion
2028-06-01
First posted
2026-01-13
Last updated
2026-01-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07337564. Inclusion in this directory is not an endorsement.

A Clinical Study Evaluating the Efficacy and Safety of SHR-1139 Injection in Adult Patients With Ulcerative Pyoderma Gan (NCT07337564) · Clinical Trials Directory